Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effects of PG102 on Allergy-related Risk Factors: A Randomized, Double Blind, Placebo Controlled Study

NCT01106703 is registered in ClinicalTrials.gov with Seoul National University Hospital as lead sponsor.

NCT NCT01106703
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01106703 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effects of PG102 on Allergy-related Risk Factors: A Randomized, Double Blind, Placebo Controlled Study
Lead sponsor
Seoul National University Hospital
Phase
Phase 2
Overall status
Completed
Start date
December 31, 2006
Completion date
April 30, 2008
Enrollment
90 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

asymptomatic subjects with atopy and elevated serum ige